Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICAM1 | P05362 | 12/20 | 0.54 |
| ▸ | SELE | P16581 | 11/20 | 0.46 |
| ▸ | VCAM1 | P19320 | 4/20 | 0.46 |
| ▸ | PIM1 | P11309 | 6/20 | 0.42 |
| ▸ | GSK3A | P49840 | 6/20 | 0.42 |
| ▸ | GSK3B | P49841 | 6/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 6/20 | 0.42 |
| ▸ | PRKACA | P17612 | 5/20 | 0.42 |
| ▸ | CDK1 | P06493 | 5/20 | 0.42 |
| ▸ | CDK2 | P24941 | 5/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.42 |
| ▸ | DAPK3 | O43293 | 4/20 | 0.42 |
| ▸ | KDR | P35968 | 4/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 4/20 | 0.42 |
| ▸ | RPS6KA3 | P51812 | 4/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.42 |
| ▸ | CSNK1D | P48730 | 4/20 | 0.42 |
| ▸ | PLK1 | P53350 | 4/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19780462 | 1.00 | ICAM1 (0.54) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL19769117 | 0.82 | ICAM1 (0.56) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL7053106 | 0.76 | ICAM1 (0.55) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL12115043 | 0.75 | CDK8 (0.41) | RPS6KB1JAK3CDK8 | |
| SCHEMBL19769172 | 0.74 | ICAM1 (0.51) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL19780763 | 0.73 | ICAM1 (0.64) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL19769134 | 0.70 | ICAM1 (0.46) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL7056240 | 0.70 | ICAM1 (1.00) | ICAM1SELEVCAM1PIM1GSK3A | |
| SCHEMBL12115005 | 0.70 | CDK8 (0.45) | JAK3CDK8 | |
| SCHEMBL19780864 | 0.70 | ICAM1 (0.46) | ICAM1SELEVCAM1PIM1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180015077-A1 | COMPOUNDS AND METHODS FOR TREATING HIV INFECTION | NAKAMURA, ROBERT | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015077-A1 | COMPOUNDS AND METHODS FOR TREATING HIV INFECTION | CD4, CCR5, MMP8 | ICAM1 65/4885SELE 751/4885VCAM1 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.